KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Receivables (2016 - 2025)

Teladoc Health's Change in Receivables history spans 12 years, with the latest figure at -$17.5 million for Q4 2025.

  • For Q4 2025, Change in Receivables fell 531.16% year-over-year to -$17.5 million; the TTM value through Dec 2025 reached -$25.1 million, down 6800.27%, while the annual FY2025 figure was -$25.1 million, 6800.27% down from the prior year.
  • Change in Receivables for Q4 2025 was -$17.5 million at Teladoc Health, down from -$16.2 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $27.8 million in Q1 2022 and bottomed at -$17.5 million in Q4 2025.
  • The 5-year median for Change in Receivables is $3.3 million (2021), against an average of $2.3 million.
  • The largest annual shift saw Change in Receivables tumbled 580.36% in 2023 before it skyrocketed 815.89% in 2025.
  • A 5-year view of Change in Receivables shows it stood at -$8.2 million in 2021, then surged by 146.04% to $3.8 million in 2022, then skyrocketed by 152.07% to $9.6 million in 2023, then tumbled by 57.62% to $4.0 million in 2024, then crashed by 531.16% to -$17.5 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Change in Receivables are -$17.5 million (Q4 2025), -$16.2 million (Q3 2025), and -$6.8 million (Q2 2025).